-
FDA approves Bristol-Myers Squibb's, AstraZeneca's Farxiga
SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug made by Bristol-Myers Squibb and AstraZeneca for treating Type 2 diabetes, the agency said Wednesday.
The FDA announced the approval of Farxiga (dapagliflozin) tablets, designed for use with exercise and dietary adjustments to control blood sugar. Type 2 diabetes affects about 24 million people in the United States, accounting for more than 90% of diabetes cases.
-
Big Y, En-Vision America partner on adherence tool for visually impaired
SPRINGFIELD, Mass. — Big Y pharmacies and En-Vision America have recently partnered on a pair of novel programs designed to improve compliance among seniors with impaired vision.
"The pharmacists are engaging with all patients and making them aware of this new service," Jan Winn, Big Y director of pharmacy, HABC and GM, shared with DSN. "The larger print labels are a big hit with the 'babyboom' generation."